期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Advanced glycation end product:A potential biomarker for risk stratification of non-alcoholic fatty liver disease in ELSA-Brasil study 被引量:1
1
作者 Evelyn Nunes Goulart da Silva Pereira daniela polessa paula +4 位作者 Beatriz Peres de Araujo Maria de Jesus Mendes da Fonseca Maria de Fátima Haueisen Sander Diniz Anissa Daliry Rosane Harter Griep 《World Journal of Gastroenterology》 SCIE CAS 2021年第29期4913-4928,共16页
BACKGROUND Liver diseases are associated with the excess formation of advanced glycation end products(AGEs),which induce tissue inflammation and oxidative damage.However,the trend of oxidative marker levels according ... BACKGROUND Liver diseases are associated with the excess formation of advanced glycation end products(AGEs),which induce tissue inflammation and oxidative damage.However,the trend of oxidative marker levels according to the steatosis grade in non-alcoholic fatty liver disease(NAFLD)is unclear.AIM To compare serum AGE levels between participants with NAFLD accordingly to steatosis severity in the baseline ELSA-Brasil population.METHODS In 305 individuals at baseline ELSA-Brasil,NAFLD-associated steatosis was classified by ultrasound hepatic attenuation.The participants were grouped according to the severity of steatosis:mild and moderate/severe pooled.The measurement of serum fluorescent AGE concentrations was based on spectrofluorimetric detection.Serum AGE content and clinical and laboratory characteristics of the participants were compared between groups.The correlation between serum AGE levels and the grade of steatosis was analyzed.Logistic regression analysis was used to investigate the relationship between serum AGE levels and steatosis severity.A P value<0.05 was considered statistically significant.RESULTS According to the steatosis severity spectrum in NAFLD,from mild to moderate/severe,individuals with the most severe steatosis grade had a higher incidence of metabolic syndrome(63%vs 34%,P≤0.001),diabetes mellitus(37%vs 14%,P≤0.001),and high cholesterol levels(51%vs 33%,P<0.001).Moreover,individuals with increasing severity of steatosis presented increasing waist circumference,body mass index,systolic and diastolic blood pressure,fasting blood glucose,glycated hemoglobin,insulin,triglycerides,alanine aminotransferase,gamma-glutamyl transferase,C-reactive protein,and uric acid levels and lower high-density lipoprotein.Higher serum AGE content was present in the moderate/severe group of individuals than in the mild group(P=0.008).In addition,the serum AGE levels were correlated with the steatosis grade in the overall sample(rho=0.146,P=0.010).Logistic regression analysis,after adjusting for confounding variables,showed that subjects with higher serum AGE content had a 4.6-fold increased chance of having moderate or severe steatosis when compared to low levels of serum AGEs.According to the results of the receiver operator characteristic curves analyses(areas under the curve,AUC=0.83),AGEs could be a good marker of steatosis severity in patients with NAFLD and might be a potential biomarker in predicting NAFLD progression,strengthening the involvement of AGE in NAFLD pathogenesis.CONCLUSION NAFLD-associated steatosis was associated with serum AGE levels;therefore,plasmatic fluorescent AGE quantification by spectroscopy could be a promising alternative method to monitor progression from mild to severe NAFLD accordingly to steatosis grade. 展开更多
关键词 Advanced glycation end products Non-alcoholic fatty liver disease STEATOSIS ELSA-Brasil study Spectroscopy
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部